About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Chronic Hepatitis B Infection Could Rise In Australia

by Gopalan on October 25, 2009 at 10:16 AM
Font : A-A+

 Chronic Hepatitis B Infection Could Rise In Australia

Chronic hepatitis B infection (HBV) could rise in Australia, says a new report, released by the Australian Centre for Economic Research on Health (ACERH) at the Australian National University (ANU).

The Impact of Chronic Hepatitis B in Australia: Projecting Mortality, Morbidity and Economic Impact, co-authored by Professor Jim Butler and Dr Rosemary Korda at ANU, and two clinicians, suggests that a national strategy involving a coordinated approach to screening, vaccination, and treatment of the disease is warranted.

Advertisement

"There appears to be a lack of appreciation of the potential benefits of identifying and treating those infected," said Dr Korda. "Although Australia has adopted universal hepatitis B vaccination for infants, there are many people already infected for whom vaccination offers no benefit.

"Immigration patterns, the ageing of the infected pool of individuals and the small number of people receiving HBV drug therapy, together imply that the long-term pathology of HBV infection can be expected to become increasingly evident over the next decade."
Advertisement

According to the report, under current levels of medical management and treatment:

The number of people living with chronic hepatitis B infection will increase from 187 000 to 276 000

The number of deaths attributable to chronic hepatitis B each year will increase from 450 in 2008 to 1550 in 2017

There will be a three-fold increase in the number of people living with liver cancer directly caused by hepatitis B.

The researchers say that increases in the rate of infection could be mitigated through the development of a national strategy for Hepatitis B, which would increase awareness of the disease and encourage those infected to seek treatment.

"Our cost-effectiveness analyses indicate investment in such a strategy is economically justified given the looming increase in the numbers of people infected and the drug therapies that are available to treat those infected," said Professor Butler.



Source: Medindia
GPL
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge on Liver Transplantation
Organ Donation Week 2022 - 'Take the Pledge to Save Lives'
Test your Knowledge on Heart Transplantation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Hepatitis A Hepatitis B Hepatitis B Virus Silent Killer Diseases Liver Flu Aplastic Anemia HBV Screening Hepatitis Needlestick Injuries 

Most Popular on Medindia

Color Blindness Calculator Diaphragmatic Hernia Selfie Addiction Calculator Drug Side Effects Calculator Loram (2 mg) (Lorazepam) Find a Hospital Drug Interaction Checker Drug - Food Interactions Blood Donation - Recipients How to Reduce School Bag Weight - Simple Tips
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use